Tag Archives: MACK

Best Clean Energy Stocks To Watch For 2019

Clean energy stocks in 2018 are on the cusp of massive growth, as the sector is projected to expand by 500% in the United States alone…

The Energy Information Agency is projecting renewable energy production to grow 500% by 2040.

The World’s First “Universal Fuel”: Physicists have known about an unlimited source of free fuel for over 100 years. See why tech companies are investing millions in this fuel (and how to join them). Click here…

And that means right now is the time to invest in clean energy stocks before they begin to soar.

To help Money Morning readers profit from the massive industry growth ahead, we’re giving our readers one of the best clean energy stocks to buy right now. More on that pick in just a bit, but we want to first show you why the renewable energy sector is set to soar…

How Renewables Will Power Clean Energy Stocks in 2018

There are three major catalysts propelling alternative energy sources to explosive growth potential. And as the sector grows, so will renewable energy stocks…

Best Clean Energy Stocks To Watch For 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Bloomin’ Brands (NASDAQ:BLMN) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By Joseph Griffin]

    Equities research analysts expect Bloomin’ Brands Inc (NASDAQ:BLMN) to report earnings per share of $0.08 for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for Bloomin’ Brands’ earnings. The highest EPS estimate is $0.12 and the lowest is $0.05. Bloomin’ Brands reported earnings of $0.12 per share during the same quarter last year, which indicates a negative year over year growth rate of 33.3%. The business is scheduled to issue its next earnings report on Friday, November 2nd.

  • [By Sean Williams]

    The casual-dining restaurant stock I’d most suggest avoiding in this industry is Bloomin’ Brands (NASDAQ:BLMN), the parent of Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Steakhouse.

Best Clean Energy Stocks To Watch For 2019: Valspar Corporation (VAL)

Advisors’ Opinion:

  • [By Max Byerly]

    Valorbit (CURRENCY:VAL) traded 0% higher against the dollar during the 1 day period ending at 11:00 AM Eastern on June 9th. One Valorbit coin can currently be bought for approximately $0.0001 or 0.00000001 BTC on exchanges. Valorbit has a market cap of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last 24 hours. In the last seven days, Valorbit has traded up 5.8% against the dollar.

  • [By Shane Hupp]

    Shares of ValiRx Plc (LON:VAL) rose 5.6% during mid-day trading on Thursday . The company traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). Approximately 587,748 shares were traded during trading, a decline of 85% from the average daily volume of 3,820,000 shares. The stock had previously closed at GBX 1.80 ($0.02).

  • [By Stephan Byrd]

    Valorbit (CURRENCY:VAL) traded up 0% against the U.S. dollar during the 1 day period ending at 0:00 AM E.T. on June 18th. One Valorbit coin can now be bought for approximately $0.0001 or 0.00000001 BTC on popular exchanges. Valorbit has a total market capitalization of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last day. During the last week, Valorbit has traded 5.8% higher against the U.S. dollar.

Best Clean Energy Stocks To Watch For 2019: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod (finance.yahoo.com) Merrimack Fails Phase 2 Pancreatic Cancer Study, But Opportunity Remains (seekingalpha.com) Merrimack Pharmaceuticals’ (MACK) “Hold” Rating Reaffirmed at Robert W. Baird (americanbankingnews.com) Merrimack Crashes as Phase II Pancreatic Cancer Study Fails (zacks.com) MM-141 (benzinga.com)

    Several equities analysts have commented on MACK shares. Zacks Investment Research raised Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research report on Wednesday, April 25th. JPMorgan Chase & Co. downgraded Merrimack Pharmaceuticals from a “neutral” rating to an “underweight” rating in a research report on Monday. Robert W. Baird cut their price objective on Merrimack Pharmaceuticals from $12.00 to $7.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, ValuEngine raised Merrimack Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Tuesday.

  • [By Chris Lange]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) shares were absolutely crushed on Monday after the firm gave an update from its midstage pancreatic cancer study. Specifically, the top-line results come from the CARRIE study, a randomized Phase 2 trial evaluating the addition of MM-141 (istiratumab) to standard-of-care treatment in patients with previously untreated metastatic pancreatic cancer.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

Best Clean Energy Stocks To Watch For 2019: Timken Company (TKR)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine downgraded shares of Timken (NYSE:TKR) from a sell rating to a strong sell rating in a research report sent to investors on Monday.

    A number of other research firms have also recently commented on TKR. Bank of America increased their target price on Timken from $50.00 to $51.00 and gave the company an underperform rating in a research note on Tuesday, May 22nd. Stifel Nicolaus upgraded shares of Timken from a hold rating to a buy rating and upped their price target for the company from $52.00 to $60.00 in a research report on Monday, May 28th. Zacks Investment Research lowered shares of Timken from a buy rating to a hold rating in a research report on Wednesday, March 21st. Vertical Research upgraded shares of Timken from a hold rating to a buy rating in a research report on Friday, May 4th. Finally, CL King began coverage on shares of Timken in a research report on Thursday, June 28th. They set a neutral rating for the company. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and seven have assigned a buy rating to the stock. Timken currently has a consensus rating of Hold and an average target price of $52.83.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Timken (TKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    CryptoInsight (CURRENCY:TKR) traded flat against the dollar during the 24 hour period ending at 21:00 PM Eastern on September 11th. One CryptoInsight token can now be purchased for about $0.0040 or 0.00000063 BTC on major exchanges including HitBTC and IDEX. Over the last week, CryptoInsight has traded down 15.8% against the dollar. CryptoInsight has a market cap of $49,784.00 and $0.00 worth of CryptoInsight was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Bank of Montreal Can acquired a new position in shares of Timken Co (NYSE:TKR) during the second quarter, HoldingsChannel reports. The firm acquired 2,822 shares of the industrial products company’s stock, valued at approximately $123,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Timken (TKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Watch Right Now

Northern Trust Corp increased its holdings in Medical Properties Trust, Inc. (NYSE:MPW) by 3.3% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 8,342,841 shares of the real estate investment trust’s stock after purchasing an additional 265,411 shares during the quarter. Northern Trust Corp’s holdings in Medical Properties Trust were worth $108,457,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. First Dallas Securities Inc. purchased a new stake in shares of Medical Properties Trust in the 4th quarter worth about $106,000. Signaturefd LLC purchased a new stake in shares of Medical Properties Trust in the 1st quarter worth about $102,000. Smith Asset Management Group LP boosted its position in shares of Medical Properties Trust by 93.4% in the 1st quarter. Smith Asset Management Group LP now owns 8,351 shares of the real estate investment trust’s stock worth $108,000 after buying an additional 4,032 shares in the last quarter. Assetmark Inc. boosted its position in shares of Medical Properties Trust by 485.0% in the 4th quarter. Assetmark Inc. now owns 9,676 shares of the real estate investment trust’s stock worth $133,000 after buying an additional 8,022 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC purchased a new stake in shares of Medical Properties Trust in the 1st quarter worth about $149,000. Institutional investors and hedge funds own 78.29% of the company’s stock.

Top Medical Stocks To Watch Right Now: Shaw Communications Inc.(SJR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shaw Communications (TSE:SJR.B) (NYSE:SJR) had its price objective boosted by analysts at National Bank Financial from C$28.00 to C$29.00 in a report issued on Wednesday. The firm currently has a “sector perform” rating on the stock. National Bank Financial’s price target would suggest a potential upside of 4.50% from the company’s current price.

  • [By Shane Hupp]

    Montrusco Bolton Investments Inc. trimmed its position in shares of Shaw Communications Inc Class B (NYSE:SJR) (TSE:SJR.B) by 10.0% during the third quarter, HoldingsChannel reports. The firm owned 89,067 shares of the company’s stock after selling 9,913 shares during the period. Montrusco Bolton Investments Inc.’s holdings in Shaw Communications Inc Class B were worth $1,734,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Shaw Communications Inc (TSE:SJR.B) (NYSE:SJR) announced a monthly dividend on Monday, May 14th, TickerTech reports. Stockholders of record on Wednesday, May 30th will be paid a dividend of 0.0988 per share on Wednesday, May 30th. This represents a $1.19 dividend on an annualized basis and a dividend yield of 4.57%. The ex-dividend date of this dividend is Monday, May 14th.

  • [By Garrett Baldwin]

    The price of Bitcoin surged more than 17% to top $8,000 in a rapid move that surprised many investors this morning. The sudden rally appears to be the result of a short squeeze, according to CNBC contributor Brian Kelly. This means that investors who had been betting on a decline in the price of the world’s largest cryptocurrency had been forced to jump back and buy the currency again. A lot of people have been betting on a decline in the price of Bitcoin heading toward the April 17 tax deadline. The expectation is that many people will need to sell their Bitcoin in order to raise cash to meet tax obligations. Here’s our latest daily insight on why the Bitcoin bear market may end very soon.
    Markets gains have been capped by concerns about the latest news out of the Federal Reserve. On Wednesday, minutes from the Fed’s most recent meeting indicated that policy makers are prepared to raise interest rates several more times in the coming months in order to stave off concerns about inflation.
    Four Stocks to Watch Today: BLK, FB, DAL
    Shares of BlackRock Inc. (NYSE: BLK) are on the move after the company reported earnings before the bell. The firm reported earnings per share (EPS) of $6.70. Analysts projected the firm would report EPS of $6.45 on top of $3.28 billion in revenue. The firm topped revenue expectations. The firm noted that an increase in its consulting fees and the recent tax reform bill helped bolster its profitability by 27%.
    The stock of Facebook Inc. (Nasdaq: FB) has climbed more than 6% since Tuesday. Investors cheered the testimony of CEO Mark Zuckerberg, who appeared before Congress for two days to discuss his company’s privacy policies. The CEO and his firm have been under intense scrutiny since news broke that 87 million user accounts had been accessed without permission by consulting firm Cambridge Analytica during the 2016 election season. The firm had ties to President Trump’s campaign.
    Delta Air Lines Inc. (NYSE: DAL) reported ea

  • [By Joseph Griffin]

    ITV PLC/ADR (OTCMKTS: ITVPY) and Shaw Communications Inc Class B (NYSE:SJR) are both mid-cap consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, analyst recommendations, profitability, institutional ownership and valuation.

  • [By Anders Bylund]

    Let me introduce you to Canadian cable company Shaw Communications (NYSE:SJR), retail-focused REIT Realty Income (NYSE:O), and equity investment firm Main Street Capital (NYSE:MAIN). All of these companies send out monthly dividend payments.

Top Medical Stocks To Watch Right Now: First Horizon National Corporation(FHN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Cadence Capital Management LLC boosted its holdings in First Horizon National Corp (NYSE:FHN) by 173.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,515 shares of the financial services provider’s stock after buying an additional 19,357 shares during the quarter. Cadence Capital Management LLC’s holdings in First Horizon National were worth $544,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Zurcher Kantonalbank Zurich Cantonalbank increased its position in First Horizon National Co. (NYSE:FHN) by 26.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,122 shares of the financial services provider’s stock after buying an additional 3,761 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in First Horizon National were worth $341,000 at the end of the most recent quarter.

  • [By Motley Fool Staff]

    First Horizon National (NYSE:FHN) Q2 2018 Earnings Conference CallJul. 17, 2018 9:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By ]

    In this environment, investors should be looking to add the banks to their portfolios. He likes Goldman Sachs (GS) and First Horizon National (FHN) , which appeared on “Mad Money” last week. He would avoid any high-yielding stock however, as they are getting increased competition from risk-free Treasuries.

  • [By Logan Wallace]

    First Horizon National (NYSE:FHN) will be posting its quarterly earnings results before the market opens on Thursday, July 12th.

    First Horizon National (NYSE:FHN) last posted its earnings results on Friday, April 13th. The financial services provider reported $0.34 EPS for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.04. First Horizon National had a return on equity of 9.37% and a net margin of 12.30%. The business had revenue of $437.20 million for the quarter, compared to analysts’ expectations of $438.60 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The business’s revenue was up 42.6% compared to the same quarter last year. On average, analysts expect First Horizon National to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Top Medical Stocks To Watch Right Now: Marlin Business Services Corp.(MRLN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    First Bank (NASDAQ: FRBA) and Marlin Business Services (NASDAQ:MRLN) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

  • [By Motley Fool Transcribers]

    Marlin Business Services Corp  (NASDAQ:MRLN)Q4 2018 Earnings Conference CallFeb. 01, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Medical Stocks To Watch Right Now: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

  • [By Max Byerly]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod (finance.yahoo.com) Merrimack Fails Phase 2 Pancreatic Cancer Study, But Opportunity Remains (seekingalpha.com) Merrimack Pharmaceuticals’ (MACK) “Hold” Rating Reaffirmed at Robert W. Baird (americanbankingnews.com) Merrimack Crashes as Phase II Pancreatic Cancer Study Fails (zacks.com) MM-141 (benzinga.com)

    Several equities analysts have commented on MACK shares. Zacks Investment Research raised Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research report on Wednesday, April 25th. JPMorgan Chase & Co. downgraded Merrimack Pharmaceuticals from a “neutral” rating to an “underweight” rating in a research report on Monday. Robert W. Baird cut their price objective on Merrimack Pharmaceuticals from $12.00 to $7.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, ValuEngine raised Merrimack Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Tuesday.

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK) by 22.0% in the second quarter, HoldingsChannel.com reports. The fund owned 174,774 shares of the biopharmaceutical company’s stock after acquiring an additional 31,509 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Merrimack Pharmaceuticals were worth $858,000 as of its most recent filing with the SEC.

Top Medical Stocks To Watch Right Now: Neuberger Berman MLP Income Fund Inc.(NML)

Advisors’ Opinion:

  • [By Ethan Ryder]

    New Millennium Iron Corp (TSE:NML)’s share price reached a new 52-week low during trading on Monday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 21500 shares traded. The stock had previously closed at C$0.07.

  • [By Logan Wallace]

    Neuberger Berman MLP Income Fund Inc (NYSEAMERICAN:NML) declared a monthly dividend on Monday, October 1st, Wall Street Journal reports. Investors of record on Monday, December 17th will be given a dividend of 0.055 per share by the investment management company on Monday, December 31st. This represents a $0.66 dividend on an annualized basis and a dividend yield of 7.42%. The ex-dividend date is Friday, December 14th.

Top Medical Stocks To Watch Right Now: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    Seadrill’s rally demonstrates how profitable penny stocks can be for savvy investors. With Seadrill’s gains already on the books, we’ll look at a stock that’s on track to generate tremendous returns – a small cap that just completed a groundbreaking acquisition with huge profit potential…

    Penny Stock Current Share Price Law Week’s Gain
    Seadrill Ltd. (NYSE: SDRL) $0.58 98.74%
    Vivis Inc. (Nasdaq: VVUS) $0.83 59.97%
    MEI Pharma Inc. (Nasdaq: MEIP) $3.45 43.40%
    Transenterix Inc. (NYSE: TRXC) $3.15 35.72%
    Akers Biosciences Inc. (Nasdaq: AKER) $0.65 34.38%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $4.54 32.58%
    Phoenix New Media Ltd. (NYSE ADR: FENG) $5.65 32.22%
    Heat Biologics Inc. (Nasdaq: HTBX) $1.73 31.37%
    Bright Scholar Education Ltd. (NYSE ADR: BEDU) $18.51 29.03%
    21 Vianet Group Inc. (Nasdaq: VNET) $7.36 28.72%

    These gains are incredibly exciting. However, not all penny stocks are equally strong investments.

  • [By Logan Wallace]

    Media stories about VIVUS (NASDAQ:VVUS) have been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. VIVUS earned a news impact score of 0.13 on Accern’s scale. Accern also gave press coverage about the biopharmaceutical company an impact score of 47.022479468622 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
     Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

Hot Blue Chip Stocks To Watch Right Now

As we know, the broad stock market indices have been resilient all year. And that strength, in large part, can be credited to a small group of stocks.

Among that group, the blue chip Internet stocks have led the way: Facebook, Amazon, Apple, Google and Netflix. Halfway through the year, those five stocks were up more than 40% on average. And those five stocks carry a lot of weight in the performance of the indexes.

And given the valuation of the index, you constantly hear how the market is overvalued or "fairly valued." It’s not true, for the reasons we’ve often discussed, related to historical low interest rates environments. And it’s certainly not true for the energy sector.

Take a look at energy performance year-to-date relative to the rest of the market:

Hot Blue Chip Stocks To Watch Right Now: Rubicon Technology, Inc.(RBCN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Rubicon Technology (NASDAQ:RBCN) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Thursday.

Hot Blue Chip Stocks To Watch Right Now: Tahoe Resources, Inc.(TAHO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) – Equities research analysts at National Bank Financial reduced their FY2018 earnings estimates for shares of Tahoe Resources in a research report issued on Monday, April 9th. National Bank Financial analyst M. Parkin now forecasts that the company will earn $0.29 per share for the year, down from their prior forecast of $0.35. National Bank Financial currently has a “Sector Perform” rating and a $8.00 price objective on the stock.

Hot Blue Chip Stocks To Watch Right Now: Simmons First National Corporation(SFNC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Simmons First National Co. (NASDAQ:SFNC) reached a new 52-week high and low during trading on Friday . The stock traded as low as $31.10 and last traded at $30.80, with a volume of 3453 shares traded. The stock had previously closed at $30.95.

Hot Blue Chip Stocks To Watch Right Now: Carrols Restaurant Group Inc.(TAST)

Advisors’ Opinion:

  • [By Stephan Byrd]

    BidaskClub upgraded shares of Carrols Restaurant Group (NASDAQ:TAST) from a strong sell rating to a sell rating in a report released on Wednesday.

    Several other research analysts also recently commented on the stock. ValuEngine raised shares of Carrols Restaurant Group from a sell rating to a hold rating in a report on Tuesday. Zacks Investment Research downgraded shares of Carrols Restaurant Group from a buy rating to a hold rating in a report on Saturday, May 5th. Dougherty & Co reaffirmed a buy rating on shares of Carrols Restaurant Group in a report on Sunday, March 4th. Finally, Citigroup cut their price objective on shares of Carrols Restaurant Group from $16.00 to $15.00 and set a buy rating for the company in a report on Monday, March 5th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of $14.50.

  • [By Lisa Levin] Gainers
    Integrated Media Technology Limited (NASDAQ: IMTE) rose 30.8 percent to $22.00 in pre-market trading after declining 18.63 percent on Monday.
    Nevsun Resources Ltd. (NYSE: NSU) rose 14.5 percent to $3.40 in pre-market trading after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Sharing Economy International Inc. (NASDAQ: SEII) rose 15.2 percent to $4.25 in pre-market trading after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Veeco Instruments Inc. (NASDAQ: VECO) shares rose 14.1 percent to $19.50 in pre-market trading after reporting stronger-than-expected earnings for its first quarter.
    Impinj, Inc. (NASDAQ: PI) rose 13.4 percent to $15.40 in pre-market trading after reporting Q1 results.
    SandRidge Energy, Inc. (NYSE: SD) shares rose 13.2 percent to $16.45 in pre-market trading following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 12.6 percent to $4.55 in pre-market trading after jumping 171.14 percent on Monday.
    Crocs, Inc. (NASDAQ: CROX) shares rose 10 percent to $16.66 in pre-market trading after the company reported better-than-expected earnings for its first quarter and issued strong sales forecast for the second quarter.
    Pareteum Corporation (NASDAQ: TEUM) rose 9.7 percent to $3.05 in pre-market trading after announcing Q1 results.
    Dean Foods Company (NYSE: DF) rose 8 percent to $9.00 in pre-market trading after reporting upbeat Q1 earnings.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 7.3 percent to $23.45 in pre-market trading following Q1 results.
    IAMGOLD Corporation (NYSE: IAG) rose 7.1 percent to $6.09 in pre-market trading after reporting upbeat Q1 earnings.
    TC PipeLines, LP (NYSE: TCP) rose 6.4 percent to $27 in pre-market trading after gaining 2.08 percent on Monday.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 6.3 percent to $11.75 in pre-market trading fol
  • [By Steve Symington]

    Burger King franchisee Carrols Restaurant Group, Inc. (NASDAQ:TAST) announced strong first-quarter 2018 results on Tuesday morning, showcasing continued momentum in both comparable-restaurant sales and revenue from acquired locations over the past year. Carrols was also able to considerably narrow its losses in this seasonally slow quarter.

  • [By Lisa Levin] Gainers
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 50.7 percent to $4.34 after the company announced a special $1.00 per share cash dividend.
    Impinj, Inc. (NASDAQ: PI) surged 28.4 percent to $17.44 after reporting Q1 results.
    Cardlytics, Inc. (NASDAQ: CDLX) gained 22 percent to $17.945.
    Care.com, Inc. (NYSE: CRCM) shares rose 19.3 percent to $18.92 following Q1 earnings.
    Sharing Economy International Inc. (NASDAQ: SEII) jumped 19.1 percent to $4.3934 after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Blink Charging Co. (NASDAQ: BLNK) rose 18.6 percent to $4.79 after jumping 171.14 percent on Monday.
    IntriCon Corporation (NASDAQ: IIN) climbed 17.4 percent to $29.30 after reporting Q1 results.
    Nevsun Resources Ltd. (NYSE: NSU) rose 16.2 percent to $3.45 after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Tactile Systems Technology, Inc. (NASDAQ: TCMD) gained 15.4 percent to $42.61 following Q1 results.
    eGain Corporation (NASDAQ: EGAN) gained 15.3 percent to $10.55 following Q3 earnings.
    Dean Foods Company (NYSE: DF) rose 13.8 percent to $9.48 after reporting upbeat Q1 earnings.
    Sterling Construction Company, Inc. (NASDAQ: STRL) shares surged 13.1 percent to $13.42 after reporting Q1 results.
    USA Technologies, Inc. (NASDAQ: USAT) climbed 11.9 percent to $10.85 following better-than-expected Q3 earnings.
    scPharmaceuticals Inc. (NASDAQ: SCPH) gained 11.2 percent to $14.45 following Q1 results.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 10.2 percent to $24.08 following Q1 results.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 7.9 percent to $19.60 as the company posted upbeat Q1 results and raised its outlook.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 7.7 percent to $11.90 following upbeat Q1 results.
    Pareteum Corporation (NASDAQ: TEUM) rose 6.8 perc

Hot Blue Chip Stocks To Watch Right Now: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Edited Transcript of MACK earnings conference call or presentation 8-May-18 12:30pm GMT (finance.yahoo.com) Investors Purchase High Volume of Merrimack Pharmaceuticals Call Options (MACK) (americanbankingnews.com) Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1 (finance.yahoo.com) Merrimack Pharmaceuticals (MACK) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS (americanbankingnews.com) Merrimack Pharmaceuticals’ (MACK) CEO Richard Peters on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)

    A number of equities analysts have issued reports on MACK shares. Robert W. Baird reiterated a “hold” rating and issued a $12.00 price objective on shares of Merrimack Pharmaceuticals in a report on Thursday, March 15th. Zacks Investment Research upgraded Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective for the company in a report on Wednesday, April 25th.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

Top Medical Stocks To Buy For 2018

Boston, MA, based Investment company North Tide Capital, Llc buys Impax Laboratories, Allergan PLC, Accuray, sells Community Health Systems, Valeant Pharmaceuticals International, Mylan NV, Perrigo Co PLC, Select Medical Holdings during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, North Tide Capital, Llc. As of 2016-12-31, North Tide Capital, Llc owns 14 stocks with a total value of $483 million. These are the details of the buys and sells.

New Purchases: IPXL, AGN, ARAY, Added Positions: MYGN, KND, Reduced Positions: MYL, SEM, SVU, GILD, LPNT, Sold Out: CYH, VRX, PRGO, AFAM, ADUS,

For the details of NORTH TIDE CAPITAL, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=NORTH+TIDE+CAPITAL%2C+LLC

These are the top 5 holdings of NORTH TIDE CAPITAL, LLCSelect Medical Holdings Corp (SEM) – 10,000,000 shares, 27.46% of the total portfolio. Shares reduced by 23.66%SUPERVALU Inc (SVU) – 18,469,921 shares, 17.87% of the total portfolio. Shares reduced by 24.61%Gilead Sciences Inc (GILD) – 500,000 shares, 7.42% of the total portfolio. Shares reduced by 37.5%Kindred Healthcare Inc (KND) – 4,250,000 shares, 6.91% of the total portfolio. Shares added by 6.25%Syneron Medical Ltd (ELOS) – 3,500,000 shares, 6.09% of the total portfolio. New Purchase: Impax Laboratories Inc (IPXL)

North Tide Capital, Llc initiated holdings in Impax Laboratories Inc. The purchase prices were between $12.75 and $24.23, with an estimated average price of $17.1. The stock is now traded at around $9.15. The impact to the portfolio due to this purchase was 5.49%. The holdings were 2,000,000 shares as of 2016-12-31.

Top Medical Stocks To Buy For 2018: Biotricity (BTCY)

Advisors’ Opinion:

  • [By Robert J. Smith]

    Biotricity (OTCBB: BTCY) is a comer in the rapidly growing medical device market and is a small cap to take notice of. Driving this lucrative market are; IoT-driven device connectivity, governmental pressure to cut healthcare costs, escalating hospital costs, a need to reduce hospital readmission rates, an aging population, and a high rate of people with chronic disease. The largest factor driving this market is the rapidly growing rate of those afflicted with chronic disease.

  • [By Peter Graham]

    Sandhill.com recently interviewed the chairman, CEO and founder Waqaas Al-Siddiq small cap wearables stock Biotricity (OTCQB: BTCY) about how wearables benefit patients, integrate into healthcare systems and improve treatment compliance as well as how the cloud and the Internet of Things impact the medical wearables space. biotricitys is a medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. biotricitys R&D focuses on the preventative healthcare market, with a vision of putting health management into the hands of the individual by supporting the self-management of critical and chronic conditions.

  • [By Matthew Briar]

    Ever heard the term ‘mHealth’? Or, maybe you’ve heard it by the full-length (and less hip) characterization mobile health. Regardless of what you call it, it’s the same … it’s the Q&D way to describe the new era of healthcare and medical equipment that operates outside of a hospital or clinic, and doesn’t require any wires to function. It’s the new way of taking care of patients, and more important, it’s a huge market. The mHealth market is projected to grow from $13.6 billion in 2015 to $49.1 billion by 2020, as the premise and technology hits a critical mass.

    It’s an undertow – a paradigm shift – that favors lots of small cap stocks, but perhaps none as much as Biotricity Inc (OTCMKTS:BTCY).

    Biotricity isn’t a household name. It may be soon, however. It’s the developer of two different but related wearable, 24/7 heart monitoring technologies. The device called bioflux is for use by caregivers in a clinical setting, remotely transmitting detailed information about the heart’s functioning which can then be analyzed by caregivers. The device known as biolife serves individuals outside of a clinical setting, largely doing the same chore. The advantage of the technology is mobility, without sacrificing accuracy.

    The device furthest along the development path is bioflux. The company recently filed a 510k request with the FDA for its bioflux technology (the 510k path is for medical devices rather than drugs, and as such doesn’t require a lot of regulatory deliberation), and has heard back from the FDA about a key part of the device already – it got the green light. Another arm of the FDA must look at other aspects of the device.

    The two devices utilize the same basic technology, but are clearly addressing different markets.

    It must also be noted that the ECG monitoring software found in a bioflux has been approved by the FDA in the past and is already rather standard technology for ECG monitoring equipment in hospitals and

Top Medical Stocks To Buy For 2018: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Paul Ausick]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped nearly 11% on Tuesday to post a new 52-week low of $3.30 after closing at $3.67 on Monday. Volume was more than 3 times the daily average of about 3.7 million shares. The stock’s 52-week high is $9.02 The company said Tuesday that it has sold some of its cancer drugs to Ipsen for $1 billion.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

Top Medical Stocks To Buy For 2018: L.B. Foster Company(FSTR)

Advisors’ Opinion:

  • [By Lee Jackson]

    The L.B. Foster Co. (NASDAQ: FSTR) had one of itsdirectors adding to a position last week. Legion Partners bought 72,301 shares of the transportation and energy infrastructure company at prices between $12.27 and $13.07. The total for the purchase came in right at $1 million. The shares closed Friday at $13.30, in a 52-week range of$9.25 to $20.77. The consensus price target is $15.00.

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Intrepid Potash, Inc. (NYSE: IPI) and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lisa Levin]

    Wednesday afternoon, basic materials shares gained by 1.74 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), and L.B. Foster Co (NASDAQ: FSTR).

Top Medical Stocks To Buy For 2018: American Express Company(AXP)

Advisors’ Opinion:

  • [By Paul Ausick]

    American Express Co. (NYSE: AXP) traded up 0.57% at $88.70. The stock’s 52-week range is $59.50 to $89.38. Volume was about half the daily average of around 3.2 million. The company had no specific news Tuesday.

  • [By Cooper Creagan]

    Since then, the money spent using prepaid cards has nearly doubled, as big players like Wal-Mart Stores Inc. (NYSE: WMT) and American Express Co. (NYSE: AXP) have entered the game with the prepaid Bluebird card.

  • [By Garrett Baldwin]

    The Ripple coin topped $0.23 after a 10% surge during Thursday trading. The price surged after credit card giant American Express Co. (NYSE: AXP) announced it has established a payments corridor between the United States and the United Kingdom using Ripple’s technology.

  • [By Paul Ausick]

    American Express Co. (NYSE: AXP) traded up 1.41% at $99.36. The stock’s 52-week range is $75.51 to $102.39. Volume was about 10% above the daily average of around 3.4 million shares. The company had no news Wednesday.

  • [By Chris Lange]

    American Express Co. (NYSE: AXP) will share its latest quarterly earnings on Wednesday. The consensus estimates call for $1.48 in EPS and $8.29 billion in revenue. Shares ended last week at $92.86, in a 52-week range of $59.78 to $92.92. The consensus analyst target is $89.91.

  • [By Paul Ausick]

    American Express Co. (NYSE: AXP) traded down 0.64% at $73.89. The stock’s 52-week range is $50.27 to $75.74. Volume was less than half the daily average of around 4.7 million shares. The company had no specific news.

Top 10 Bank Stocks To Own Right Now

Federal law requires public companies like Wells Fargo to warn shareholders about non-routine legal proceedings.

Yet it has now emerged that Wells Fargo stayed silent for at least six months about the fact that authorities were investigating the bank’s creation of fake accounts.

Wells Fargo (WFC) confirmed on Thursday that it was in talks with the Consumer Financial Protection Bureau about unauthorized accounts as early as March 2016. This comes after the Charlotte Observer obtained emails under the Freedom of Information Act that revealed the discussions between the bank and the regulator.

The revelations will intensify questions over why Wells Fargo never alerted investors in public statements or public filings about the risk posed by what turned out to be a damaging investigation.

Wells Fargo’s September settlement with the CFPB and other regulators tarnished the storied bank’s reputation, hurt its stock price, led to the sudden retirement of CEO John Stumpf and included $185 million in fines.

Top 10 Bank Stocks To Own Right Now: Tandy Leather Factory, Inc.(TLF)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

Top 10 Bank Stocks To Own Right Now: Liberty Global plc(LBTYA)

Advisors’ Opinion:

  • [By Alex Webb]

    Kabel Deutschland is a key part of Vodafones expansion strategy as the carrier looks for ways to boost revenue and lock in customers with Internet and television offers in addition to wireless service. Kabel Deutschland is the biggest cable company in Germany, Vodafones largest market, and had drawn a rival bid from John Malones Liberty Global Plc. (LBTYA)

Top 10 Bank Stocks To Own Right Now: China Mobile (Hong Kong) Ltd.(CHL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, telecommunications services shares fell 0.12 percent. Meanwhile, top losers in the sector included China Mobile Ltd. (ADR) (NYSE: CHL), down 3 percent, and Partner Communications Company Ltd (ADR) (NASDAQ: PTNR), down 1.5 percent.

  • [By Motif Investing]

    The most heavily weighted names in the motif are China Mobile Ltd. (ADR) (NYSE: CHL), Aibaba Group Holding Ltd (NYSE: BABA), Baidu Inc (NASDAQ: BIDU), India's HDFC Bank (NYSE: HDB) and Russia's Mobile TeleSystems PJSC (NYSE: MBT).

  • [By David Goodboy]

    Rumors are that Apple will use this opportunity to announce the long-awaited deal with China Mobile (NYSE: CHL), which is the world's largest cellphone carrier with more than 700 million active users. Clearly, there are impediments in the way, but the potential for a lower-priced iPhone for this market means strong possibilities remain. This deal would be a major upside catalyst for Apple shares.

Top 10 Bank Stocks To Own Right Now: Sirius XM Radio Inc.(SIRI)

Advisors’ Opinion:

  • [By Ashley Moore]

    But before we get to the stock pick, here’s a list of the 10 top-performing Warren Buffett stocks so far this year…

    Company YTD Gains
    Moody’s Corp. (NYSE: MCO) 34.25%
    Apple Inc. (Nasdaq: AAPL) 30.24%
    Verisign Inc. (Nasdaq: VRSN) 29.88%
    Restaurant Brands Inc. (NYSE: QSR) 29.16%
    WABCO Holdings Inc. (NYSE: WBC) 28.97%
    Visa Inc. (NYSE: V) 26.20%
    Liberty Sirius XM Group Class C (Nasdaq: LSXMK) 24.54%
    MasterCard Inc. (NYSE: MA) 24.35%
    Liberty Sirius XM Group Class A (Nasdaq: LSXMA) 22.89%
    Sirius XM Holdings Inc. (Nasdaq: SIRI) 22.81%

    Again, we don’t recommend all of the stocks above for retail investors. After all, Warren Buffett is one of the most wealthy and legendary investors in history. He has a completely different set of goals from us.

  • [By Jon C. Ogg]

    The long saga regarding Pandora Media Inc. (NYSE: P) has finally come to a head. Well, maybe. Rather than KKR & Co. L.P. (NYSE: KKR) investing $150 million, Sirius XM Holdings Inc. (NASDAQ: SIRI) will be investing up to $480 million in the streaming music rival. With its ticketing unit sale taking place as well, it might seem that Pandora is getting a great deal and helping to bolster its books.

  • [By Jon C. Ogg]

    Sirius XM Holdings Inc. (NASDAQ: SIRI) is a company that thrives on of new car sales. If you have had satellite radio and are not solely reliant on what you get for music in streaming or your library, then chances are pretty good that you won’t want to go back to just having old-fashioned FM/AM radio.

  • [By Rick Munarriz]

    There are a lot of people betting against Sirius XM Radio (NASDAQ:SIRI)these days, even as the stock is hitting 10-year highs. There were 280.1 million shares of Sirius XM sold short at the end of 2016, just below the late-November peak of 285.1 million shares but nearly double the short interest that we were seeing a year ago.

  • [By Peter Graham]

    A long term performance chart shows Pandora Mediapeaking in 2014 before heading back to where it started while other streaming media stocks such as large cap satellite radio stockSirius XM Radio Inc (NASDAQ: SIRI) has performed better and InternetTV stock Netflix, Inc (NASDAQ: NFLX) has been a homerun:

Top 10 Bank Stocks To Own Right Now: Pacira Pharmaceuticals, Inc.(PCRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pacira Pharmaceuticals Inc (NASDAQ: PCRX) shares were also up, gaining 17 percent to $39.80. Pacira Pharmaceuticals reported preliminary 2016 revenue of $276.4 million.

  • [By Chris Lange]

    Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) has announced preliminary unaudited total revenues and net product sales for Exparel for the fourth quarter and the full year. Total revenues were $72.9 million and $276.4 million for the fourth quarter and full year, respectively. Exparel net product sales were $71.4 million and $239.9 million for the same periods, respectively. The consensus estimates from Thomson Reuters were calling for revenues of $72.56 million in the fourth quarter and $276.09 million in the full year.

Top 10 Bank Stocks To Own Right Now: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Paul Ausick]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped 9% on Thursday to post a new 52-week low of $3.72 after closing at $4.09 on Wednesday. Volume was more than double the daily average of about 3 million shares. The company had no specific news Thursday.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Paul Ausick]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped about 19% on Wednesday to post a new 52-week low of $4.35 against a 52-week high of $9.02 and a Tuesday close of $5.37. Volume of nearly 11 million was more than 3 times the daily average of around 3.4 million. The company said this morning that it is ending its breast cancer treatment study.

Top 10 Bank Stocks To Own Right Now: Public Service Enterprise Group Incorporated(PEG)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Jefferies announced on Tuesday that it has upgraded Public Service Enterprise Group Inc. (PEG).

    The firm has lifted its rating on PEG from “Hold” to “Buy,” and has raised the company’s price target from $36 to $37. This price target suggests a 12% increase from the stock’s current price of $32.42.

    Analyst Paul Fremont commented: “We are upgrading to Buy based on the improving outlook for regulatory approval of the company’s “Energy Strong” capital spending program.

    “Each $1.0 billion of incremental spending will add an estimated $0.10 to PEG’s earnings. We assume that incremental spending is funded by debt and by incremental cash expected from the increasing gas basis differential between the Leidy hub and New Jersey. Our new estimates are considerably higher than consensus in 2014-16.”

    Public Service Enterprise Group shares were mostly flat during pre-market trading Tuesday. The stock is up 6% YTD.

Top 10 Bank Stocks To Own Right Now: Fiat Chrysler Automobiles N.V.(FCAM)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The showstopper by far in the early going is Waymo’s self-driving minivan (pictured below) in partnership with Fiat Chrysler (FCAM) . Waymo’s ultimate mom-mobile, coming from a business that was spun-off from Google’s parent company Alphabet Inc. (GOOG) last month, is equipped with self-driving sensors and vision systems.

Top 10 Bank Stocks To Own Right Now: Shutterfly Inc.(SFLY)

Advisors’ Opinion:

  • [By Chris Lange]

    When Shutterfly Inc. (NASDAQ: SFLY) released its fourth-quarter earnings report after the markets closed on Wednesday, the company said it had $2.63 in earnings per share (EPS) and $561.2 million in revenue. The consensus estimates had called for $2.84 in EPS and revenue of $586.4 million. In the same period of last year, it posted EPS of $3.57 and $548.1 million in revenue.

Top 10 Bank Stocks To Own Right Now: Preferred Bank(PFBC)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Preferred Bank (PFBC) has surged 54% in the past year but still trades at a modest discount to the median S&P 1500 regional bank, based on both trailing earnings and estimated 2017 profits.